(Information sent by the signatory company)

-New CAS BioFinder Discovery Platform enables drug discovery scientists to reveal insights, drive innovation and save time

Transformative new scientific insights capabilities combine an unparalleled collection of curated scientific data with advanced predictive models to accelerate innovation in early-stage drug discovery.

COLUMBUS, Ohio, May 21, 2024 /PRNewswire/ — Today, CAS, a division of the American Chemical Society specializing in scientific knowledge management, announced the launch of the CAS BioFinder Discovery Platform™, a comprehensive life sciences offering that will reveal novel insights through unprecedented data connections. The new offering provides drug discovery scientists the ability to explore known and predicted data, find answers to their questions quickly and reliably, and accelerate the preclinical drug discovery process.

“As the volume and complexity of scientific content grows, drug discovery scientists spend too much time analyzing data,” said Manuel Guzmán, president of CAS. “R&D organizations that partner with CAS will be empowered to navigate the overwhelming amount of scientific information and gain the insights they need to bring innovative, life-saving medicines to market.”

CAS BioFinder Discovery Platform leverages scientific content through the CAS Content Collection™, which includes the world’s most comprehensive and highly structured human-curated scientific data. In addition to connecting biological sequences, structure-activity relationship data, ADME measurement and toxicity to its substance collection, CAS more recently incorporated biomarker data linked to diseases and drugs. CAS leveraged Chemotargets CLARITY® as the technology foundation for the predictive and analytical capabilities of CAS BioFinder™.

Combining this wealth of scientific knowledge with patented AI-powered technology and an intuitive visual interface, the CAS BioFinder Discovery Platform is designed to assist drug discovery scientists in their research, just as CAS SciFinder® has served chemists and related scientists for decades.

Through the CAS BioFinder Discovery Platform, users can explore empirical data and run predictive models to understand the potential effects of new molecules. The new platform also includes API access to bioactivity and biomarker data that scientists will be able to process using their internal models. Over time, users will benefit from fully integrated innovation capabilities that span their spectrum of data, research and workflow needs.

To ensure that the CAS BioFinder Discovery Platform addresses scientists’ most prominent pain points in drug discovery, last year CAS convened a Life Sciences Industry Advisory Council comprised of global thought leaders from commercial, academic and and government that have guided the organization’s journey into the life sciences. An initial version of CAS BioFinder was also shared with several industry partners whose feedback helped strengthen the solution from the beginning.

“Our mission with the CAS BioFinder Discovery Platform is to help early-stage drug discovery scientists advance their research more efficiently and safely so they can solve the types of therapeutic problems that excited them to begin their research in the first place. ,” said Dr. Michael Dennis, Chief Scientific Officer, CAS. “The solution enables scientists to find, collect, understand and trust the scientific content they need, seamlessly use it to run analytical and predictive models, and discover the answers and insights to ultimately drive their research, so that the world doesn’t have to wait for the next drug discovery.

The CAS BioFinder Discovery Platform will continue to evolve and improve to meet the needs of drug discovery scientists.

Learn more about the CAS BioFinder Discovery Platform at https://www.cas.org/solutions/biofinder-discovery-platform.

About CAS

CAS connects the world’s scientific knowledge to accelerate advances that improve lives. We empower global innovators to efficiently navigate today’s complex data landscape and make confident decisions at every phase of the innovation journey. As a scientific knowledge management specialist, our team creates the world’s largest authoritative collection of human-curated scientific data and provides essential information solutions, services and expertise. Scientists, patent professionals, and business leaders across industries rely on CAS to help them uncover opportunities, mitigate risks, and unlock shared knowledge so they can move from inspiration to innovation faster. CAS is a division of the American Chemical Society. Connect with us at cas.org.

Photo – https://mma.prnewswire.com/media/2416010…Logo – https://mma.prnewswire.com/media/1729161…

View original content: https://www.prnewswire.com/news-releases/nueva-cas-biofinder-discovery-platform-permite-a-los-cientificos-impulsar-la-innovacion-302149467.html